Four years later, the same team published a manuscript in which MMP-2/TIMP-2 complex levels were measured in plasma obtained from 126 patients with lymphomas (HL = 31, non-Hodgkin lymphoma (NHL) = 95) and 44 healthy controls. This evidence concerns the gene TIMP2 and lymphoma.